Literature DB >> 35648341

All-Cause Mortality Risk Prediction in Older Adults with Cancer: Practical Approaches and Limitations.

Andrea Perez-de-Acha1, Sophie Pilleron2, Enrique Soto-Perez-de-Celis3.   

Abstract

PURPOSE OF REVIEW: The prediction of all-cause mortality is an important component of shared decision-making across the cancer care continuum, particularly in older adults with limited life expectancy, for whom there is an increased risk of over-diagnosis and treatment. RECENT
FINDINGS: Currently, several international societies recommend the use of all-cause mortality risk prediction tools when making decisions regarding screening and treatment in geriatric oncology. Here, we review some practical aspects of the utilization of those tools and dissect the characteristics of those most employed in geriatric oncology, highlighting both their advantages and their limitations.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cancer; Clinical decision rules; Decision-making; Life expectancy; Mortality; Older adults; Prognosis

Year:  2022        PMID: 35648341     DOI: 10.1007/s11912-022-01303-2

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  44 in total

1.  Competing risk of death: an important consideration in studies of older adults.

Authors:  Sarah D Berry; Long Ngo; Elizabeth J Samelson; Douglas P Kiel
Journal:  J Am Geriatr Soc       Date:  2010-03-22       Impact factor: 5.562

2.  Cancer survival: an overview of measures, uses, and interpretation.

Authors:  Angela B Mariotto; Anne-Michelle Noone; Nadia Howlader; Hyunsoon Cho; Gretchen E Keel; Jessica Garshell; Steven Woloshin; Lisa M Schwartz
Journal:  J Natl Cancer Inst Monogr       Date:  2014-11

Review 3.  Predicting Life Expectancy for Older Adults with Cancer in Clinical Practice: Implications for Shared Decision-making.

Authors:  Haydee Cristina Verduzco-Aguirre; Carolina Gomez-Moreno; Yanin Chavarri-Guerra; Enrique Soto-Perez-de-Celis
Journal:  Curr Oncol Rep       Date:  2019-06-25       Impact factor: 5.075

4.  How we use noncancer-specific survival prediction in geriatric oncology: A Young International Society of Geriatric Oncology and Nursing & Allied Health Interest Group initiative.

Authors:  Carolina Gómez-Moreno; Sophie Pilleron; Nina Rosa Neuendorff; Enrique Soto-Perez-de-Celis
Journal:  J Geriatr Oncol       Date:  2021-10-21       Impact factor: 3.599

5.  Accuracy of Oncologists' Life-Expectancy Estimates Recalled by Their Advanced Cancer Patients: Correlates and Outcomes.

Authors:  Jason Lambden; Baohui Zhang; Robert Friedlander; Holly G Prigerson
Journal:  J Palliat Med       Date:  2016-08-30       Impact factor: 2.947

6.  Development and validation of a prognostic index for 4-year mortality in older adults.

Authors:  Sei J Lee; Karla Lindquist; Mark R Segal; Kenneth E Covinsky
Journal:  JAMA       Date:  2006-02-15       Impact factor: 56.272

Review 7.  Functional versus chronological age: geriatric assessments to guide decision making in older patients with cancer.

Authors:  Enrique Soto-Perez-de-Celis; Daneng Li; Yuan Yuan; Yat Ming Lau; Arti Hurria
Journal:  Lancet Oncol       Date:  2018-06-01       Impact factor: 41.316

8.  Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology Summary.

Authors:  Supriya G Mohile; William Dale; Mark R Somerfield; Arti Hurria
Journal:  J Oncol Pract       Date:  2018-06-22       Impact factor: 3.840

Review 9.  Decision Making in Older Adults With Cancer.

Authors:  Clark DuMontier; Kah Poh Loh; Enrique Soto-Perez-de-Celis; William Dale
Journal:  J Clin Oncol       Date:  2021-05-27       Impact factor: 50.717

Review 10.  What Every Oncologist Should Know About Geriatric Assessment for Older Patients With Cancer: Young International Society of Geriatric Oncology Position Paper.

Authors:  Kah Poh Loh; Enrique Soto-Perez-de-Celis; Tina Hsu; Nienke A de Glas; Nicolò Matteo Luca Battisti; Capucine Baldini; Manuel Rodrigues; Stuart M Lichtman; Hans Wildiers
Journal:  J Oncol Pract       Date:  2018-02       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.